# SYNTHESIS JOURNAL EDITORIAL REVIEW

**Journal:** Research Synthesis Methods / Systematic Reviews
**Manuscript:** PyTSA: Advancing Evidence Synthesis Through Open-Source Trial Sequential Analysis
**Review Date:** November 18, 2025
**Reviewer:** Senior Editor, Evidence Synthesis Methods

---

## EXECUTIVE SUMMARY

**Recommendation:** ⚠️ **MAJOR REVISIONS REQUIRED**

**Overall Assessment:** The manuscript presents valuable methodological work on Trial Sequential Analysis software implementation. However, critical issues with word count compliance, data precision, and one uncited claim require correction before publication.

**Quality Score:** 7/10 (can reach 9/10 with revisions)

---

## DETAILED REVIEW

### 1. SCOPE AND SUITABILITY FOR SYNTHESIS JOURNAL ✅

**Verdict: EXCELLENT FIT**

This manuscript is highly appropriate for a synthesis methods journal:
- Addresses core methodology in evidence synthesis (TSA)
- Provides practical tool for systematic reviewers
- Validates against established standards
- Discusses implications for living systematic reviews and GRADE
- Open-source implementation advances reproducible research

**Strengths:**
- Clear focus on advancing synthesis methodology
- Practical relevance to systematic review practice
- Addresses current gap in transparent TSA tools

---

### 2. WORD COUNT COMPLIANCE ❌

**Verdict: NON-COMPLIANT**

**Required:** 1000 words (excluding references)
**Current:** 891 words (main text + figure legends)
**Deficit:** 109 words short

**Issue:** The manuscript is 11% below the requested word count.

**Required Action:** Expand main text by ~110 words to reach 1000 words. Suggested areas:
- Expand "Practical Implications" section (currently very condensed)
- Add 1-2 sentences on limitations in Conclusions
- Slightly expand "Future Development" section

---

### 3. DATA ACCURACY VERIFICATION

#### 3.1 Validation Statistics ✅ MOSTLY ACCURATE

**Line 37: "mean absolute error of 0.33%"**
- ✅ **VERIFIED:** Methods paper line 587 confirms 0.33%
- Status: ACCURATE

**Line 37: "correlation r=0.9998, p<0.001"**
- ✅ **VERIFIED:** Methods paper line 589 confirms r=0.9998, p<0.001
- Status: ACCURATE

**Line 37: "within 0.10% for effect estimates"**
- ✅ **VERIFIED:** Methods paper Table 2 shows RR difference of 0.0007 = 0.10%
- Status: ACCURATE

**Line 37: "1.38% for heterogeneity statistics"**
- ✅ **VERIFIED:** Methods paper line 520 shows τ² error = 1.38%
- Status: ACCURATE

**Line 37: "within 0.13%"**
- ✅ **VERIFIED:** Methods paper line 32 states "within 0.13%"
- Status: ACCURATE

**Line 37: "94.3% coverage"**
- ✅ **VERIFIED:** Methods paper line 617 states "94.3%"
- Status: ACCURATE

**Line 37: "20 scenarios"**
- ✅ **VERIFIED:** Methods paper line 585 confirms 20 test scenarios
- Status: ACCURATE

**Line 37: "three published TSA analyses"**
- ✅ **VERIFIED:** Methods paper Examples 1-3 (lines 556-582)
- Status: ACCURATE

#### 3.2 Critical Data Errors ⚠️

**Line 39: "±1.4% of expected values"**
- ❌ **ERROR:** Maximum error is **1.38%**, not 1.4%
- Source: Methods paper line 588: "Maximum absolute percentage error: **1.38%**"
- **Required correction:** Change to "±1.38%"
- **Severity:** MODERATE (rounding introduced imprecision)

**Line 55: "mean errors <0.5%"**
- ✅ **ACCURATE:** 0.33% < 0.5% ✓
- Status: CORRECT

**Line 74: "mean difference is 0.002%"**
- ✅ **VERIFIED:** Methods paper line 593: "Mean difference (bias): 0.002"
- Status: ACCURATE

**Line 74: "±1.4%"** (Limits of Agreement)
- ⚠️ **INCONSISTENT:** Methods paper line 594 states "95% limits of agreement: -0.024 to 0.028"
- **Analysis:** If these are percentages, the range is -2.4% to +2.8%, not ±1.4%
- **Issue:** The synthesis uses ±1.4% but the methods paper shows asymmetric limits
- **Required action:**
  - Option A: Change to "-2.4% to +2.8%" for accuracy
  - Option B: If -0.024 to 0.028 are on a different scale, clarify units
- **Severity:** MODERATE to HIGH (affects interpretation of agreement)

#### 3.3 Uncited Claims ⚠️

**Line 19: "up to 40% of apparently conclusive Cochrane meta-analyses become inconclusive"**
- ⚠️ **MISSING CITATION**
- Likely source: Reference [3] Imberger et al. 2016, BMJ Open
- Methods paper line 1061 confirms this paper examines false-positive findings in Cochrane MAs
- **Required action:** Add citation: "Studies show [3] that up to 40%..."
- **Severity:** MODERATE (strong claim needs support)

**Line 25: "over 1,000 published systematic reviews"**
- ✅ **CITED:** Reference [10] Castellini et al. 2018
- Note: Data from 2018; number likely higher in 2025 but conservatively stated
- Status: ACCEPTABLE

#### 3.4 Figure Data Verification ✅

**Figure 1 Panel B (Line 67):**
- Claim: "1,780 of 3,000 patients" = 59% of RIS
- Calculation: 1780/3000 = 0.593 = 59.3% ✓
- Claim: "approximately 1,220 additional patients needed"
- Calculation: 3000 - 1780 = 1,220 ✓
- **Status: ACCURATE**

**Figure 2 Panel A (Line 75):**
- Claims: r=0.9998, MAE=0.33%, 20 test scenarios
- All verified above ✓
- **Status: ACCURATE**

**Figure 2 Panel B (Line 75):**
- Mean difference: 0.002% ✓
- LoA: ±1.4% ⚠️ (see issue above)
- **Status: PENDING CORRECTION**

---

### 4. STATISTICAL REPORTING QUALITY

**Overall: GOOD with minor issues**

✅ **Strengths:**
- Appropriate precision (2 decimal places for correlations)
- P-values properly reported
- Effect sizes with standard errors/CIs mentioned
- Comparison with multiple reference standards
- Transparent reporting of all validation metrics

⚠️ **Weaknesses:**
1. Rounding 1.38% to 1.4% introduces imprecision
2. Bland-Altman LoA inconsistency needs resolution
3. One uncited statistic (40% claim)

---

### 5. FIGURE QUALITY ASSESSMENT ✅

**Figure 1: TSA Conceptual Framework**
- ✅ **Excellent:** Clear, publication-ready, pedagogically effective
- Appropriately demonstrates both conclusive and inconclusive scenarios
- Legend is detailed and accurate
- Color scheme is appropriate
- **Rating: 9/10**

**Figure 2: Validation Results**
- ✅ **Excellent:** Professional presentation of validation data
- Scatter plot and Bland-Altman are standard for validation studies
- Statistics clearly presented
- **Minor issue:** LoA values need verification
- **Rating: 8.5/10** (9.5 after LoA correction)

**Overall Figure Assessment:** Both figures are publication-ready pending minor corrections.

---

### 6. SYNTHESIS-SPECIFIC EVALUATION

#### 6.1 Integration of Evidence ✅
- **Excellent:** Synthesizes the rationale, methodology, validation, and implications
- Connects TSA to broader evidence synthesis challenges
- Discusses relationship to GRADE, living reviews

#### 6.2 Methodological Rigor ✅
- **Strong:** Comprehensive validation approach
- Multiple comparison standards (Copenhagen TSA, R packages, published analyses)
- Appropriate statistical methods (correlation, Bland-Altman, test coverage)

#### 6.3 Practical Relevance ✅
- **Excellent:** Clear implications for systematic reviewers
- Addresses real gaps in current software ecosystem
- Discusses implementation in living systematic reviews

#### 6.4 Transparency ✅
- **Outstanding:** Open-source, version-controlled, DOI-assigned
- Reproducible figures (Python scripts provided)
- Complete data availability statement

---

### 7. WRITING QUALITY

**Overall: VERY GOOD**

✅ **Strengths:**
- Clear, accessible prose
- Logical flow from problem → solution → validation → implications
- Appropriate technical depth for synthesis journal
- Good use of topic sentences

⚠️ **Minor issues:**
- Some sections feel rushed/condensed (e.g., Practical Implications)
- Could benefit from 1-2 sentences on limitations
- Abstract could be slightly tightened

---

### 8. REFERENCE QUALITY ✅

**Overall: EXCELLENT**

- 12 references appropriately selected
- Mix of foundational TSA papers, software papers, and applications
- All citations appear accurate
- Appropriate journal-style formatting

**Suggested addition:** Cite reference [3] for the 40% statistic

---

## REQUIRED CORRECTIONS (MANDATORY)

### Critical Priority:
1. ❌ **Line 39:** Change "±1.4%" to "±1.38%" for maximum error
2. ❌ **Line 74:** Verify and correct Bland-Altman LoA from "±1.4%" to accurate values ("-2.4% to +2.8%" or clarify units)
3. ❌ **Line 19:** Add citation [3] to "40%" claim
4. ❌ **Word count:** Expand from 891 to ~1000 words

### Medium Priority:
5. Remove or update the word count note (lines 130-132) after expansion
6. Consider adding 1-2 sentences on limitations in Conclusions

---

## DETAILED CORRECTIONS NEEDED

### Correction 1: Maximum Error Precision
**Location:** Line 39
**Current:**
> "All RIS calculations fall within ±1.4% of expected values"

**Corrected:**
> "All RIS calculations fall within ±1.38% of expected values"

**Rationale:** Methods paper specifies exactly 1.38%; rounding to 1.4% introduces imprecision inappropriate for a validation study.

---

### Correction 2: Bland-Altman Limits of Agreement
**Location:** Line 74
**Current:**
> "All differences fall within narrow 95% limits of agreement (red dashed lines, ±1.4%)"

**Investigation Required:**
Methods paper states: "95% limits of agreement: -0.024 to 0.028"

**Possible interpretations:**
1. If these are already percentages: "-2.4% to +2.8%"
2. If these are proportions: "-2.4% to +2.8%"
3. If on different scale: Need clarification

**Recommended correction:**
> "All differences fall within narrow 95% limits of agreement (red dashed lines, -2.4% to +2.8%)"

**Action needed:** Verify the actual LoA values from the Bland-Altman analysis in the methods paper and update accordingly.

---

### Correction 3: Add Citation
**Location:** Line 19
**Current:**
> "Studies show that up to 40% of apparently conclusive Cochrane meta-analyses become inconclusive when proper sequential monitoring is applied."

**Corrected:**
> "Studies show [3] that up to 40% of apparently conclusive Cochrane meta-analyses become inconclusive when proper sequential monitoring is applied."

**Rationale:** Strong empirical claim requires citation support.

---

### Correction 4: Expand Word Count

**Target:** Add ~110 words to reach 1000-word count

**Suggested expansions:**

**A. Practical Implications section (current: 65 words):**
Add 2-3 sentences on specific use cases:
- Example of using PyTSA in protocol development
- How TSA results inform "no further research needed" decisions
- Integration with automated systematic review platforms

**B. Conclusions section:**
Add 1-2 sentences on limitations:
- Current limitations of TSA methodology (not PyTSA specifically)
- Need for community validation and feedback

**C. Future Development section:**
Expand on one planned feature (e.g., network meta-analysis TSA)

---

## OPTIONAL ENHANCEMENTS

1. **Abstract tightening:** Could reduce abstract from 122 to ~100 words for punchier impact
2. **Add subheadings:** Consider breaking longer sections with subheadings
3. **Graphical abstract:** Many synthesis journals now welcome graphical abstracts - Figure 1 Panel B could be adapted
4. **Supplementary material:** Consider moving detailed validation table to supplement

---

## COMPARISON TO METHODS PAPER

The synthesis appropriately condenses the full methods paper:
- ✅ Captures key validation metrics accurately
- ✅ Focuses on synthesis-relevant aspects
- ✅ Maintains scientific rigor while being accessible
- ✅ Appropriate length for synthesis journal

**Relationship:** The synthesis serves as an excellent companion piece to the methods paper, focusing on methodological implications rather than technical details.

---

## FINAL VERDICT

### Publication Recommendation: ✅ **ACCEPT WITH MAJOR REVISIONS**

**Rationale:**
- High-quality work addressing important methodological gap
- Excellent fit for synthesis methods journal
- Strong validation and transparency
- Clear practical implications

**However:** Critical data precision errors and word count non-compliance require correction before acceptance.

**Expected timeline:** Corrections are straightforward and can be completed in 1-2 days.

**Post-revision recommendation:** Likely **ACCEPT** after addressing the 4 mandatory corrections.

---

## CHECKLIST FOR AUTHORS

**Must complete before resubmission:**
- [ ] Correct ±1.4% to ±1.38% (line 39)
- [ ] Verify and correct Bland-Altman LoA (line 74)
- [ ] Add citation [3] to 40% claim (line 19)
- [ ] Expand text by ~110 words to reach 1000
- [ ] Update/remove word count note at end

**Strongly recommended:**
- [ ] Add 1-2 sentences on limitations in Conclusions
- [ ] Proofread all numerical values against methods paper
- [ ] Verify figure references match actual figures

**Optional:**
- [ ] Consider graphical abstract
- [ ] Tighten abstract to ~100 words

---

## REVIEWER RECOMMENDATION TO EDITOR

**This manuscript makes an important contribution to evidence synthesis methodology.** The development of open-source TSA software addresses a real gap and will benefit the systematic review community. The validation is rigorous and the presentation is clear.

**The required revisions are minor but critical** - primarily correcting numerical precision and expanding to meet word count. These should be straightforward for the authors to address.

**I recommend MAJOR REVISIONS with expectation of ACCEPTANCE** after the mandatory corrections are made.

The work is publication-worthy and will be a valuable resource for the synthesis methods community.

---

**Reviewer:** Senior Editor, Evidence Synthesis Methods
**Date:** November 18, 2025
**Conflicts:** None
**Review Time:** 2.5 hours

---

## SCORE BREAKDOWN

| Criterion | Score | Weight | Weighted |
|-----------|-------|--------|----------|
| Methodological rigor | 9/10 | 25% | 2.25 |
| Data accuracy | 7/10* | 20% | 1.40 |
| Relevance to synthesis | 10/10 | 20% | 2.00 |
| Writing quality | 8/10 | 15% | 1.20 |
| Figures | 9/10 | 10% | 0.90 |
| Transparency | 10/10 | 10% | 1.00 |

**Overall Score: 8.75/10** (*after corrections would be 9.5/10)

**Recommendation: MAJOR REVISIONS → ACCEPT**
